Curaleaf Executive Chairman of the Board Boris Jordan Says By Doing TSX Uplist Co Can Start Talking To Large Scale Institutional Investors
Portfolio Pulse from Benzinga Newsdesk
Curaleaf's Executive Chairman, Boris Jordan, has announced that by uplisting to the TSX, the company can start engaging with large scale institutional investors.
September 28, 2023 | 6:33 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Curaleaf's uplisting to TSX could attract large scale institutional investors, potentially boosting its stock price.
Uplisting to a larger exchange like TSX often attracts more institutional investors due to increased visibility and liquidity. This could lead to increased demand for the stock, potentially driving up its price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
As an ETF that tracks US cannabis companies, MSOS could indirectly benefit from Curaleaf's uplisting to TSX.
MSOS tracks US cannabis companies, including Curaleaf. If Curaleaf's stock price increases due to the uplisting, it could indirectly boost the value of MSOS.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 60